— Know what they know.
Not Investment Advice
Also trades as: 2005.HK (HKSE) · $vol 2M

LJUIF OTC

SSY Group Limited
1W: +0.0% 1M: +1.8% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -38.5% 5Y: -15.6%
$0.40
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 59 · $1.2B mcap · 988M float · 0.0001% daily turnover · Short 100% of daily vol

Income Trends

Revenue
$4.2B -27.9% ▼
5Y CAGR: -0.5%
Gross Profit
$1.6B -44.3% ▼
5Y CAGR: -8.9%
Operating Income
$406M -69.8% ▼
5Y CAGR: -11.8%
Net Income
$471M -55.7% ▼
5Y CAGR: -5.1%
EPS (Diluted)
$0.16 -55.6% ▼
5Y CAGR: -4.4%
EBITDA
$860M -53.9% ▼
5Y CAGR: -4.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$5.4B$6.4B$6.5B$5.8B$4.2B
YoY Growth+25.7%+20.1%+0.5%-10.7%-27.9%
Cost of Revenue$2.3B$3.0B$2.8B$2.9B$2.5B
Gross Profit$3.0B$3.4B$3.6B$2.9B$1.6B
Gross Margin56.7%53.5%56.0%50.4%38.9%
R&D Expenses$248M$259M$290M$266M$209M
SG&A Expenses$2.0B$1.9B$1.5B$1.1B$1.0B
Operating Expenses$2.2B$2.1B$2.0B$1.6B$1.2B
Operating Income$988M$1.4B$1.6B$1.3B$406M
Operating Margin18.4%22.1%25.4%23.3%9.8%
Interest Expense$61M$88M$125M$127M$106M
Income Before Tax$948M$1.4B$1.6B$1.3B$564M
Tax Expense$160M$210M$254M$206M$80M
Net Income$786M$1.1B$1.3B$1.1B$471M
Net Margin14.7%17.5%20.4%18.4%11.3%
EPS (Diluted)$0.26$0.38$0.44$0.36$0.16
EBITDA$1.4B$1.9B$2.1B$1.9B$860M
Shares Outstanding3.03B2.99B2.98B2.96B2.93B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms